ARCHIVES

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

“Critical Issues” Include How U.S. NCI Spends Its Money. “Catastrophic” Cutback In Canada

May 14, 1976

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

March 12, 2010

ACOS Planning Patient Care Melanoma Study

August 4, 1989

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014